Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Receivables (2020 - 2025)

iHuman has reported Receivables over the past 6 years, most recently at $7.3 million for Q4 2025.

  • Quarterly Receivables fell 11.82% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, down 11.82% year-over-year, with the annual reading at $7.3 million for FY2025, 10.39% down from the prior year.
  • Receivables was $7.3 million for Q4 2025 at iHuman, down from $8.3 million in the prior quarter.
  • Over five years, Receivables peaked at $12.3 million in Q4 2022 and troughed at $7.3 million in Q4 2025.
  • The 5-year median for Receivables is $8.7 million (2023), against an average of $9.2 million.
  • Biggest five-year swings in Receivables: plummeted 88.57% in 2021 and later surged 33.08% in 2022.
  • Tracing IH's Receivables over 5 years: stood at $9.2 million in 2021, then soared by 33.08% to $12.3 million in 2022, then decreased by 29.13% to $8.7 million in 2023, then decreased by 4.55% to $8.3 million in 2024, then fell by 11.82% to $7.3 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $7.3 million, $8.3 million, and $8.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.